Dual therapy with an angiotensin receptor blocker and a JAK1/2 inhibitor attenuates dialysate-induced angiogenesis and preserves peritoneal membrane structure and function in an experimental CKD rat model

By sjmartinez • April 5, 2023

Zhang P, Miyata KN, Nast CC, LaPage JA, Mahoney M, Nguyen S, Khan K, Wu Q, Adler SG, Dai T. Dual therapy with an angiotensin receptor blocker and a JAK1/2 inhibitor attenuates dialysate-induced angiogenesis and preserves peritoneal membrane structure and function in an experimental CKD rat model. Perit Dial Int. 2023 Mar;43(2):159-167. doi: 10.1177/08968608221116956. Epub 2022 Aug 9. PMID: 35946050.

Tags: Angiogenesis, fibrosis, Harbor UCLA, JAK inhibitor, Nephrology, peritoneal dialysis, peritoneal membrane, Publications

Aortic arch calcification in relation to cigarette smoking: results from the multi-ethnic study of atherosclerosis (MESA)

Ansari S, Trujillo R, McClelland RL, Budoff MJ. Aortic arch calcification in relation to cigarette smoking: results from the multi-ethnic study of atherosclerosis (MESA). Int[...]

Transcatheter Structural Heart Interventions in Women

Chung J, Yang K, Nozadze N, Kukarni A, Ashwath M, Bui Q, Co-Vu J, Jone PN, Lyubarova R, Andrade-Bucknor S. Transcatheter Structural Heart Interventions in[...]

Possible long COVID biomarker: identification of SARC-CoV-2 related protein(s) in Serum Extracellular Vesicles

Abbasi A, Sharma R, Hansen N, Pirrotte P, Stringer WW. Possible long COVID biomarker: identification of SARC-CoV-2 related protein(s) in Serum Extracellular Vesicles. Infection. 2025[...]